title: Cholinesterase inhibitors and Alzheimer's disease outcomes.
authors.forename: Angeles
authors.initials: A
authors.lastname: Garcia
authors.forename: Kelli
authors.initials: K
authors.lastname: Thompson
authors.forename: Katherine
authors.initials: K
authors.lastname: Zanibbi
authors.forename: Shannon
authors.initials: S
authors.lastname: Geick
authors.forename: Rachel
authors.initials: R
authors.lastname: Adams
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000175:diagnosis* / Q000453:epidemiology; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015994:Incidence; D007326:Institutionalization; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors